|

Peripheral Blood Stem Cell Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: PBSC, Peripheral Blood Stem Cells, Peripheral Stem Cells, peripheral stem cell

Pipeline

Phase 2: 3

Top Sponsors

  • Fred Hutchinson Cancer Center2
  • Children's Hospital Medical Center, Cincinnati1

Indications

  • Cancer3
  • Myelodysplastic Syndrome2
  • Acute Myeloid Leukemia2
  • Severe Marrow Failure1
  • Fanconi Anemia1

Tampa, Florida1 trial

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Moffitt Cancer Center

Phase 2

New York, New York1 trial

HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

Memorial Sloan Kettering Cancer Center

Phase 2

Seattle, Washington1 trial

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

Fred Hutch/University of Washington Cancer Consortium

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.